Shining a light on night blindness
Oct. 24, 2013—Vanderbilt researchers are studying how mutations in the receptor for light, rhodopsin, cause light blindness.
Metabolic profiling of vision loss
Sep. 27, 2013—A panel of metabolites – small molecules that are part of metabolic processes – that are unique to macular degeneration will shed light on the disease and aid diagnosis.
‘Bionic eye’ new option for retinitis pigmentosa patients
Jul. 25, 2013—Vanderbilt University Medical Center has been chosen as one of 12 sites in the United States to offer the first FDA-approved bionic eye for the treatment of retinitis pigmentosa (RP).
Insights on glaucoma gene mutations
Jun. 26, 2013—Glaucoma-causing mutations in the gene for myocilin reduce secretion of the protein into the aqueous humor, suggesting a new option for treatment.
Grants bolster eye research at Vanderbilt
Jul. 5, 2011—Research to Prevent Blindness has awarded a grant of $100,000 to Vanderbilt’s Department of Ophthalmology and Visual Sciences to support research into the causes, treatment and prevention of blinding diseases.